![](https://investorshub.advfn.com/uicon/394785.png?cb=1498059414)
Thursday, February 19, 2015 9:10:28 AM
Biobillionair Wednesday, 02/18/15 03:50:56 PM
Re: None
Post # of 42470
Oral arguments on USDC calendar today..
\
Calendar: 03/17/2015
Case Number and Title Judge Time Courtroom Purpose
07-cv-1590: SOLOMON v. JOHANNS Judge John D. Bates 09:15AM Courtroom 30A - 6th Floor Status Conference
14-cv-0068: BEYDOUN, et al v. TOWNLEY et al Judge John D. Bates 09:30AM Courtroom 30A - 6th Floor Motion Hearing
03-cr-0331: USA v. LORENZANA-CORDON Judge Colleen Kollar-Kotelly 09:30AM Courtroom 28A - 6th Floor Status Conference
14-cr-0069: USA v. YINDEEAR-ROM Judge Rosemary M. Collyer 10:00AM Courtroom 8 - 4th Floor Sentencing
11-cv-2210: WESTFAHL v. DISTRICT OF COLUMBIA et al Mag. Judge Alan Kay 10:00AM Chambers Settlement Conference
14-cv-0824: NATIONWIDE MUTUAL FIRE INSURANCE COMPANY v. POTOMAC HOLDINGS, INC. D/B/A POTOMAC ELECTRIC POWER COMPANY et al Judge Gladys Kessler 10:00AM Courtroom 26A - 4th Floor Status Conference
13-cv-1574: SMITH v. UNITED STATES OF AMERICA Judge Amit P. Mehta 10:00AM Courtroom 10 - 4th Floor Status Conference
14-cv-0535: OKPARA v. DISTRICT OF COLUMBIA et al Judge Randolph D. Moss 10:00AM Courtroom 21 - 4th Floor Status Conference
15-cv-0118: SCHLISSEL v. WASHINGTON METROPOLITAN AREA TRANSIT AUTHORITY Judge Randolph D. Moss 10:15AM Courtroom 21 - 4th Floor Scheduling Conference
14-cv-0259: COLEMAN v. ALLSTATE INSURANCE COMPANY Judge Tanya S. Chutkan 10:30AM Courtroom 2 - 2nd Floor Scheduling Conference
14-cv-1289: LITTLE et al v. WASHINGTON METROPOLITAN AREA TRANSIT AUTHORITY et al Judge Rosemary M. Collyer 11:15AM Courtroom 8 - 4th Floor Scheduling Conference
15-cr-0006: USA v. MCCORD Judge Rosemary M. Collyer 11:30AM Courtroom 8 - 4th Floor Status Conference
14-cr-0201: USA v. BOYKIN Judge Rosemary M. Collyer 11:30AM Courtroom 8 - 4th Floor Status Conference
14-cr-0201: USA v. WHITE Judge Rosemary M. Collyer 11:30AM Courtroom 8 - 4th Floor Status Conference
14-cr-0201: USA v. OLIVER Judge Rosemary M. Collyer 11:30AM Courtroom 8 - 4th Floor Status Conference
14-cv-0324: AMARIN PHARMACEUTICALS IRELAND LIMITED v. FOOD AND DRUG ADMINISTRATION et al Judge Randolph D. Moss 02:00PM Courtroom 21 - 4th Floor Motion Hearing
12-cv-1841: EGUDU v. DISTRICT OF COLUMBIA et al Judge Amy B. Jackson 02:30PM Courtroom 3 - 2nd Floor Pretrial Conference
11-cv-2174: YAH KAI WORLD WIDE ENTERPRISES, INC. et al v. NAPPER Judge Ketanji B. Jackson 02:30PM Courtroom 17 - 6th Floor Status Conference
14-cv-1831: CLEVELAND CONSTRUCTION, INC. v. HITT CONTRACTING, INC. Judge Ketanji B. Jackson 02:30PM Courtroom 17 - 6th Floor Initial Conference
98-cv-0376: USA v. VALDEZ Mag. Judge Deborah A. Robinson 02:30PM Courtroom 4 - 2nd Floor Evidentiary Hearing
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM